Business & Economics Books:

Artificial Intelligence for Drug Product Lifecycle Applications

Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Format:

Paperback / softback
$494.00
Releases

Pre-order to reserve stock from our first shipment. Your credit card will not be charged until your order is ready to ship.

Available for pre-order now
Free Delivery with Primate
Join Now

Free 14 day free trial, cancel anytime.

Buy Now, Pay Later with:

4 payments of $123.50 with Afterpay Learn more

6 weekly interest-free payments of $82.33 with Laybuy Learn more

Pre-order Price Guarantee

If you pre-order an item and the price drops before the release date, you'll pay the lowest price. This happens automatically when you pre-order and pay by credit card or pickup.

If paying by PayPal, Afterpay, Laybuy, Zip, Klarna, POLi, Online EFTPOS or internet banking, and the price drops after you have paid, you can ask for the difference to be refunded.

If Mighty Ape's price changes before release, you'll pay the lowest price.

Availability

This product will be released on

Delivering to:

It should arrive:

  • 8-15 October using International Courier

Description

Artificial Intelligence for Drug Product Lifecycle Applications explains the use of artificial intelligence (AI) in drug discovery and development paths including the clinical and post-approval phase. The book gives methods for each of the drug development steps, from the Fundamentals up to Post-approval drug product. AI is a synergistic assembly of enhanced optimization strategies with particular application in pharmaceutical development and advanced tools for promoting cost-effectiveness throughout drug lifecycle. Specifically, AI brings together the potential to improve drug approval rates, reduce development costs, get medications to patients faster and help patients comply with their treatments. Accelerated pharmaceutical development and drug product approval rates will enable larger profits from patent-protected market exclusivity. Artificial Intelligence for Drug Product Lifecycle offers the tools and knowledge to create the right AI strategy to extend the landscape of AI applications across the drug lifecycle. It will be especially useful for pharmaceutical scientists, health care professionals and regulatory scientists, as well as advanced students and postgraduates actively involved in pharmaceutical product and process development involving the use of Artificial Intelligence in drug delivery applications.

Author Biography:

Alberto Pais is Full Professor at the University of Coimbra and Director of the Department of Chemistry. He is also Head of the macromolecules, Colloids and Photochemistry research group of the Coimbra Chemistry Centre, one of the largest groups of this research centre. Possesses expertise in Physical Chemistry, Polymer Science, Polyelectrolytes and DNA technology, Modeling, Simulation, and Data Science. The main contributions are included in ca. 200 scientific articles, 2 edited book, and 18 book chapters. He also supervised 11completed PhD Thesis and many MSc theses. Participated as Principal Investigator/co-Principal Investigator/PhD Researcher in 18 projects Professor Carla Vitorino graduated in Pharmaceutical Sciences from the University of Coimbra and obtained the PhD degree in Pharmaceutical Sciences, in the specialty of Pharmaceutics, by the same institution. Currently, she is Assistant Professor at the Faculty of Pharmacy of the University of Coimbra. She has been working on the application of nanotechnology in drug permeation enhancement strategies for transdermal, oral and drug delivery systems to brain targeting, which has resulted in the publication of several scientific papers in peer-reviewed high impact journals. It brings together vast experience in pharmaceutical technology, standing out in the areas of nanotechnology and regulatory science. Her main research interests are nanotechnology, controlled release, and the development of new drug delivery systems in a Quality by Design perspective. Sandra Nunes is a Junior Researcher at Coimbra Chemistry Center, Department of Chemistry, University of Coimbra, since 2019, collaborating in the teaching component of UC. Her expertise includes the development of coarse-grained models of polyelectrolyte systems, ab initio methods and molecular dynamics simulation applied to nucleic acids behaviour, host-guest interactions, modelling of reaction-pathways and the study of the interactions between drugs/biomolecules and membranes. She published 41 papers, has 2 book chapters, 1 peer-reviewed conference proceeding, 40 communications in scientific meetings, 2 covers and 1 provisional patent application. She is member of the editorial board of 2 journals, reviewer in several international scientific journals and has been member of the jury panels of dissertations at University of Coimbra and abroad. Tânia Cova is a Junior Researcher from the Coimbra Chemistry Center, Department of Chemistry, University of Coimbra. She has completed her PhD in Chemistry - Macromolecular Chemistry, from University of Coimbra in 2018. She owes over 10 years of research experience in the field of theoretical and computational chemistry, especially on in silico studies of supramolecular systems for drug delivery, DNA-aptamer/peptide-carbohydrate conjugates to improve drug recognition in biological matrices, and tumor targeting, and on topics machine learning and big data. TC is the author of 4 book chapters, 33 articles, 1 Patent application, 2 special issue editions, 21 oral communications, and 17 conference posters. TC was nominated MC Substitute of COST Action CA19145 PT. She participated as PhD Researcher in 2 projects.
Release date NZ
October 1st, 2024
Audience
  • Professional & Vocational
Contributors
  • Edited by Alberto Pais
  • Edited by Carla Vitorino
  • Edited by Sandra Nunes
  • Edited by Tânia Cova
Pages
600
ISBN-13
9780323918190
Product ID
38596157

Customer previews

Nobody has previewed this product yet. You could be the first!

Write a Preview

Help & options

Filed under...